Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Affiliations

¹ New York University Langone Vaccine Center, New York, NY, USA.
² New York University Grossman School of Medicine, New York, NY, USA.
³ University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD, USA.
⁴ Vaccine Research and Development, Pfizer Inc, Hurley, UK.
⁵ Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. judith.absalon@pfizer.com.
⁶ Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
⁷ Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
⁸ University of Texas Medical Branch, Galveston, TX, USA.
⁹ BioNTech, Mainz, Germany.
¹⁰ University of Rochester, Rochester, NY, USA.
¹¹ Rochester General Hospital, Rochester, NY, USA.
¹² Cincinnati Children's Hospital, Cincinnati, OH, USA.

^# Contributed equally.

Published Erratum

Mark J Mulligan et al. Nature. 2021 Feb.

. 2021 Feb;590(7844):E26.

doi: 10.1038/s41586-020-03098-3.

¹ New York University Langone Vaccine Center, New York, NY, USA.
² New York University Grossman School of Medicine, New York, NY, USA.
³ University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD, USA.
⁴ Vaccine Research and Development, Pfizer Inc, Hurley, UK.
⁵ Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. judith.absalon@pfizer.com.
⁶ Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
⁷ Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
⁸ University of Texas Medical Branch, Galveston, TX, USA.
⁹ BioNTech, Mainz, Germany.
¹⁰ University of Rochester, Rochester, NY, USA.
¹¹ Rochester General Hospital, Rochester, NY, USA.
¹² Cincinnati Children's Hospital, Cincinnati, OH, USA.

^# Contributed equally.

No abstract available

Erratum for

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Şahin U, Jansen KU. Mulligan MJ, et al. Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12. Nature. 2020. PMID: 32785213 Clinical Trial.